Informations sur le produit
Nom :
Cinepazide
Synonymes :
- 1-(2-oxo-2-pyrrolidin-1-ylethyl)-4-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]piperazine
- 1-[4-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
- 1-{4-[2-Oxo-2-(Pyrrolidin-1-Yl)Ethyl]Piperazin-1-Yl}-3-(3,4,5-Trimethoxyphenyl)Prop-2-En-1-One
- 2-Propen-1-one, 1-[4-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1-piperazinyl]-3-(3,4,5-trimethoxyphenyl)-
- 23887-46-9
- Piperazine, 1-[(1-pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)-
- Piperazine, 1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-
Description :
Cinepazide is a drug that is used to treat diabetes mellitus. It is a basic protein that has been shown to have statistically significant effects on neuronal death, mitochondrial membrane potential, and enzyme activities in the mitochondria of rats. Cinepazide also has been shown to have mitochondrial functions. This drug decreases the risk of cardiovascular events in patients with coronary heart diseases and improves energy metabolism by decreasing glucose levels in the blood. Cinepazide may cause side-effects such as headache, dizziness, and nausea.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
417.5 g/mol
Formule :
C22H31N3O5
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
